السلام عليكم ورحمة الله وبركاته
شركة CDIC
وصل سعر السهم من يومين 2.66 .. والان سعره 2.93
اخر تقرير مالي
وهذا شارت الديلي
بالتوفيق ان شاء الله
تحياتي للجميع
ابو عمر
شركة CDIC
Cardiodynamics International Corporation (CardioDynamics) is engaged in the development, manufacture and marketing of non-invasive impedance cardiography (ICG) diagnostic and monitoring technologies, as well as electrocardiograph electrode sensors.
وصل سعر السهم من يومين 2.66 .. والان سعره 2.93
Revenue (ttm): 40.99M
Revenue Per Share (ttm): 0.825
Revenue Growth (lfy)³: 35.10%
Gross Profit (ttm)²: 29.35M
EBITDA (ttm): 3.26M
Net Income Avl to Common (ttm): 10.12M
Diluted EPS (ttm): 0.21
Earnings Growth (lfy)³: 312.80%
Total Cash (mrq): 6.80M
Total Cash Per Share (mrq): 0.14
Total Debt (mrq)²: 5.73M
Total Debt/Equity (mrq): 0.128
Current Ratio (mrq): 3.511
Book Value Per Share (mrq): 0.918
From Operations (ttm)³: 4.37M
Free Cashflow (ttm)³: 2.97M
Average Volume (3 month): 294,000
Average Volume (10 day): 459,000
Shares Outstanding: 48.77M
Float: 44.00M
% Held by Insiders: 9.79%
% Held by Institutions: 35.13%
Shares Short (as of 8-Feb-05): 1.08M
Daily Volume (as of 8-Feb-05): N/A
Short Ratio (as of 8-Feb-05): 6.045
Short % of Float (as of 8-Feb-05): 2.44%
Shares Short (prior month): 1.27M
52-Week High (12-Apr-04): 6.98
52-Week Low (23-Mar-05): 2.65
50-Day Moving Average: 4.13
200-Day Moving Average: 4.62
Revenue Per Share (ttm): 0.825
Revenue Growth (lfy)³: 35.10%
Gross Profit (ttm)²: 29.35M
EBITDA (ttm): 3.26M
Net Income Avl to Common (ttm): 10.12M
Diluted EPS (ttm): 0.21
Earnings Growth (lfy)³: 312.80%
Total Cash (mrq): 6.80M
Total Cash Per Share (mrq): 0.14
Total Debt (mrq)²: 5.73M
Total Debt/Equity (mrq): 0.128
Current Ratio (mrq): 3.511
Book Value Per Share (mrq): 0.918
From Operations (ttm)³: 4.37M
Free Cashflow (ttm)³: 2.97M
Average Volume (3 month): 294,000
Average Volume (10 day): 459,000
Shares Outstanding: 48.77M
Float: 44.00M
% Held by Insiders: 9.79%
% Held by Institutions: 35.13%
Shares Short (as of 8-Feb-05): 1.08M
Daily Volume (as of 8-Feb-05): N/A
Short Ratio (as of 8-Feb-05): 6.045
Short % of Float (as of 8-Feb-05): 2.44%
Shares Short (prior month): 1.27M
52-Week High (12-Apr-04): 6.98
52-Week Low (23-Mar-05): 2.65
50-Day Moving Average: 4.13
200-Day Moving Average: 4.62
اخر تقرير مالي
For the fiscal year ended 11/30/04, sales rose 35% to $41 million. Net income totalled $10.1 million, up from $2.5 million. Results reflect more BioZ placements by its domestic direct sales force, the acquisition of Vermed and higher operating margins.
وهذا شارت الديلي
بالتوفيق ان شاء الله
تحياتي للجميع
ابو عمر
